.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
RYTHM is stocked at 1,150 licensed dispensaries across New York, Illinois, and 11 other states, 179 of them in New York, with the deepest coverage in New York, Queens, Brooklyn, Staten Island, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, RYTHM’s mix tilted further toward Flower at 50.56% share with 8.25% YoY and 10.38% MoM gains, while Pre-Roll expanded to 19.71% share on 34.30% YoY and 13.74% MoM growth; Vapor Pens held 23.12% share with 14.87% YoY and 15.92% MoM increases. Concentrates, though only 5.66% share, advanced 17.52% YoY and 17.95% MoM, and Edible remained marginal at 0.87% share with 16.67% YoY and 2.64% MoM. With brand sales up 14.84% YoY as average price fell 5.51%, the pattern implies volume-led expansion anchored in high-velocity inhalables, with Flower still the center of gravity despite faster percentage growth in Pre-Roll and Concentrates.
The category shifts suggest RYTHM is consolidating a price-to-volume position in inhalables: Flower’s scale plus double-digit MoM (10.38%) supports shelf coverage, while Pre-Roll’s higher YoY (34.30%) and MoM (13.74%) likely capture value-tier and convenience occasions; Vapor Pens’ 15.92% MoM surge complements this by defending premium-adjacent segments. Given first-place rank in Flower in Nevada (rank 1) and a brand-wide 31.21% growth over 24 months alongside a 5.51% YoY price decline, the mix implies a deliberate trade-down capture that maintains category leadership in Flower while using faster-growing Pre-Roll and Concentrates to hedge against price compression.
Competitive Landscape
RYTHM sits at rank #2 in IL Flower in October 2026, unchanged from #2 in October 2025, while its 3-month position also held at #2, implying zero rank volatility even as peers moved. High Supply / Supply stayed #1 year over year but posted a 17.5% sales decline, narrowing the gap versus a flat-ranked RYTHM, whereas &Shine jumped from #8 to #4 with 53.3% YoY growth, pressuring the #3 position currently held by Good Green at #3 with 5.4% YoY growth. The pattern implies RYTHM’s steady #2—despite a declining #1 and a rapidly advancing #4—positions it for either upward capture if #1’s contraction persists or potential squeeze if challenger momentum outpaces incumbents.
Notable Products
RYTHM is priced above comparable items in October 2026, with average list prices 10.4% higher than similar products, and flagship Flower items like Animal Face (3.5g) and Brownie Scout (3.5g) carrying 22–23% premiums. That pricing stance paired with only 7.6% of sales from new launches points to sales concentrated in established higher-priced SKUs, so most of its sales ride on core, premium-priced formats.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
